ARS
Pharmalabs Ltd., India
STANDARD OPERATING PROCEDURE.
| TITLE: CORRECTIVE AND PREVENTIVE ACTIONS:
‘SOP NO.: “cawvo0s-00 DEPARTMENT: Corporate Quality
Assurance
‘SUPERSEDES SOP Training
EFFECTIVE NO.: NA PAGE NO.: Copy
1 of 11
DATEI
1.0 APPROVAL
Prepared By ~ User Department
Harsha) Samant. 03-08-2011
Name ‘Signature / Date
Reviewed By ~ Head of The User Department / Designee
Plu vax Obprom=
‘Signature /Date
Approved By ~ Head Quality Assurance / Designee
Name Signature / Date
|
PRR Rohr ude oe
CQA001/F01-00AR
Pharmalabs Ltd., India
STANDARD OPERATING PROCEDURE.
TITLE: CORRECTIVE AND PREVENTIVE ACTIONS,
'SOPNO: | caAr0so0 |DEPARTMENT: | Corporate Quality
Assurance
‘SUPERSEDES SOP era EoT
EFFECTIVE eer paceno.: | iuadiniing
DATE: Me 2oftt Copy
| DATED: NA
OBJECTIVE
To describe a comprehensive, systematic approach for managing Corrective Actions and
Preventive Actions for the resolution of non conforming events identified for systems,
procedures and standards.
3.0 SCOPE
This Standard Operating Procedure is applicable to corrective actions and preventive
actions planned or to be completed for the resolution of non conforming events identified
for systems, procedures and standards such as Incidences, Deviations, Aberrant results,
Out of trend (OOT) and Out of specification (OOS) results, Product complaints,
Validations, Annual Product Reviews, Laboratory operations, Interal audits etc.
4.0 RESPONSIBILITY
4.1. Department employees: For identification, reporting and providing information
during investigation and assessment of Effectiveness of CAPA.
4.2 Department Heads or Designee: For identification, evaluation, documentation and
implementation and assessment of effectiveness of the corrective and preventive
actions and ensure compliance to the SOP.
4.3. Head-Quality Assurance or designee is responsible for the tracking of the CAPA,
implementation and to ensure the compliance to this SOP.
5.0 DEFINITION(s)
5.1 Deviation
A deviation is a planned activity performed differently and/or modified than that
specified in an approved document that has the potential to affect the safety,
identity, strength, quality or purity of a raw or packaging material, in-process.
material or drug product , covering a specified period of time or a specified
number of batches.
SanoourD1-00 ‘Approved By orate): ESAR
Pharmalabs
Ltd., India
STANDARD OPERATING PROCEDURE.
TiTLi
SORRECTIVE AND PREVENTIVE ACTIONS
SOP NO.:
CQa00s-00 | DEPARTMENT: Corporate Quality
Assurance |
EFFECTIVE
DATE:
‘SUPERSEDES SOP ——
NO. NA PAGE NO.: i tlh
2 3of 11 opy
DATED: NA
52
53
54
55
56
6.0 PROCEDURE
64
©QA001/F01-00,
Incident
‘An incident can be defined as any untoward event, occurrence or unplanned
deviations at any stage of manufacturing, packaging, testing, holding and
distribution of drug product and/or components which may have potential to
impact on a drug product safety, identity, strength, quality or purity due to system
or process fallure, equipment breakdown, or manual error.
Corrective Action
‘Action(s) taken to resolve or correct existing non conformity, investigate to identify
the root cause, address the identified root cause(s) and/or eliminate the cause(s)
of existing non-conformance, problem, etc.
Preventive Action
Action(s) taken to eliminate root cause of potential non-conformance, defect or
undesirable situation to prevent future non conformance.
Root Cause(s)
The proven reason for the cause of the existing non conformity based upon the
results of the investigation which when addressed will prevent its recurrence ete.
Aberrant Results
Any laboratory test result (including individual data points when replicate sample
preparations are analyzed) that is demonstrated to be inconsistent with historical
data.
The requirement of the corrective and preventive actions is involved in following
events (but not limited to}
6.1.1. Deviations
6.1.2 IncidentsA
Pharmalabs Ltd., India
STANDARD OPERATING PROCEDURE
TITLE: CORRECTIVE AND PREVENTIVE ACTIONS.
soPNO.: | cQAio0s-00 | DEPARTMENT: Corporate Quality
Assurance
‘SUPERSEDES SOP
EFFECTIVE : PAGE NO.:
DATE: oe arty
DATED: NA
6.4.3 Outof trend (OOT) results
6.1.4 Out of specification (00S)
6.1.5 Product complaints
6.1.6 Process validation
6.1.7 Product recalls
6.1.8 External and Internal Audits
6.1.9 Equipment qualification
6.1.10 Cleaning validation
6.1.11 Change Control
6.1.12 Annual Product Review
| 6.1.13 Validation Master Plan
is because, they may affect:
6.2.2 Regulatory implications
6.2.3. Patient safety.
6.4 Corrective Actions
64.2.1 Remedial Actions:
6.2.1 Safety, purity, potency or effectiveness of the product.
6.4.2 The corrective actions can be divided into two sections:
6.2 The need for implementing Corrective and Preventive Actions for all these events |
6.3 Corrective and preventive action report should be filled as per Attachment # 2.
6.4.1 Corrective actions are taken to eliminate the cause of an existing non
conformity or detected undesirable event.
COA001/F 01-00 ‘Approved By (Signature) =fAR
Pharmalabs Ltd., India
STANDARD OPERATING PROCEDURE
TITLE: CORRECTIVE AND PREVENTIVE ACTIONS.
‘SOP NO.: CQA/005-00 | DEPARTMENT: Corporate Quality
Assurance
‘SUPERSEDES SOP Wg
EFFECTIVE sai PAGE NO.: Deeirtns
DATE: “ Sof 11 Opy
DATED: NA
Remedial actions are actions taken to eliminate or
control a detected non conformity prior to the root
cause determination. For eg, if a non conformity is that
an instrument has not been calibrated, the remedial
action would be to get the instrument calibrated before
finding out the root cause for non conformity.
| [Link] Root Cause determination:
This is the investigation conducted to find the pre
reason for the detected non conformity. The
investigation includes review of existing data,
discussions, past trends and situation at the time of,
detected non conformance.
6.4.3 The proposed corrective action must satisfy the following
| requirements:
[Link] Resolution of a current non conformity
64.32 Ifimmediate resolution is not possible, alternative
[Link] The various actions must be planned along with
corresponding target dates of completion,
[Link] Each proposed corrective action must have a
responsible owner.
64.3.5 Area of implementation
[Link] Description of events mentioned in proposed actions
[Link] The proposed corrective actions must be recorded in
respective formats of relevant SOP’s along with a
distinctive number for each incident.
64.3.8 _In case the detected non conformity is a recurred event,
the corrective actions planned for the earlier events must
be evaluated by a team investigating the current non
assessment must be made
CQA001/F01-00
Approved By (Signature)
conformance.AR
Pharmalabs Ltd., India
STANDARD OPERATING PROCEDURE,
TITLE: CORRECTIVE AND PREVENTIVE ACTIONS,
‘SOP NO.: CQA/005-00 | DEPARTMENT: Corporate Quality
Assurance
‘SUPERSEDES SOP
PEEECUVE ‘1 PAGE NO.:
| DATE: we 6 of 11
DATED: NA.
t = ale
For recurring events, possibility of ais
control must be evaluated.
64,3.10 Close out for Corrective Actions
65 Preventive Actions
| 6.5.1 Action(s) taken to eliminate root cause of potential nonconformance,
| defect or undesirable situation to prevent future non conformance,
Preventive action is different from corrective action in that corrective
action is taken to prevent recurrence of existing event whereas
preventive action is taken to prevent occurrence of event. It is more of
a proactive measure taken to prevent occurrence of the event on the
systems that are yet unaffected but may be potential victims of the
existing defect.
6.5.2 Preventive actions taken can be divided into two sections:
65.21 Impact Assessment:
This is a procedure by which the impact of the current
non conformity is assessed on the other systems as well |
as overall situation. The loopholes can be plugged in the
existing scenario that can affect the now unaffected
systems
Examples of impact assessment and taking steps to cur
their negative impact on the other system existing could
be an introduction of new standard operating procedure
or introduction of new system as a checkpoint to
safeguard other systems.
65.22 Continual Improvement:
This is the procedure that identifies and addresses the
Improvements in the system or procedure along with the
potential sources events. |
. g. Introduction of automatic machine, trend observed in
annual product review.
CQA001/F01-00 Awoved By Cigna) SARN
Pharmalabs Ltd., India
STANDARD OPERATING PROCEDURE
TITLE: CORRECTIVE AND PREVENTIVE ACTIONS.
‘SOP NO.: cawoos.o0 | DEPARTMENT: Corporate Quality |
Assurance
‘SUPERSEDES SOP ink
EFFECTIVE NGRA PAGENO: | ‘eat
DATE: a Toft Py
DATED: NA
6.5.3 The following continual improvement cycle can be referred for
improvements in the existing practices.
Plan
+ Define the improvement
+ Perform the impact assessment
* Create the solutions,
+ Prepare action plan.
Act
* Correct if required
+ Standardize the improvement.
Review
* Review the effectiveness of implementation.
Perform
+ Implement the actions.
CQA001/F01-00 ‘Approved By (Signature) :_ RwAR
Pharmalabs
Ltd., India
STANDARD OPERATING PROCEDURE
TITLE: CORRECTIVE AND PREVENTIVE ACTIONS:
‘SOP NO.: CQA/005-00 | DEPARTMENT: Corporate Quality
Assurance
‘SUPERSEDES SOP THamAL
EFFECTIVE age PAGE NO.: [Sige THEN
DATE: Bof 11 | Py
DATED: NA
4 During impact assessment, the control points and risks associated with
all activities within the process shall be considered.
6.5.5 The proposed preventive action must include the following:
65.5.1 Anoverall assessment of all the systems.
65.52 The various actions planned along with corresponding
target dates of completion
65.6.3 Each proposed preventive action must have a
responsible owner
65.5.4 Areas of implementation
[Link] Description of events mentioned in proposed actions
[Link] The proposed preventive actions must be recorded in
respective formats of relevant SOP's along with
distinctive number for each incident
65.5.7 Training to the personnel on the systems to be
introduced, new documentation to be prepared.
65.5.8 Review of the actions and assessment its effectiveness
over a period of time.
655.9 Follow up (if required)
6.55.10 Finalization of actions through change control procedure.
[Link] __ In case the detected non conformity is a recurred event,
the corrective actions planned for the earlier events must
be evaluated by a team investigating the current non
conformance.
655.12 For recurring events, possibilty of raising a change
control must be evaluated.
6.55.13 Close out for proposed Preventive action
CQA001/F01-00
Approved By (Signature) SeARN
Pharmalabs Ltd., India
STANDARD OPERATING PROCEDURE
TITLE: CORRECTIVE AND PREVENTIVE ACTIONS.
SOP NO.: CQA/005-00 DEPARTMENT: Corporate Quality
L | Assurance
t -
| SUPERSEDES SOP ia
| EFFECTIVE ay PAGENO.: [0 raining
DATE: i 9of11 Opy
| DATED: NA
6.6.1
662
66.3
66.4
67
674
672
67.3
674
(CQA001/F01-00
Extension of due dates for Correcti
Assessment of Effectiveness of Corrective and Preventive Actions
and Preventive Action:
All Proposed Corrective and Preventive actions must have a target
date of completion in an approved CAPA document recorded in
respective formats of relevant SOP's.
‘The CAPA dates are considered overdue if the target dates are not
met.
The extension for due dates must be approved by Site Quality
Assurance,
Following criteria must be considered for extension of due dates:
66.4.1 Appropriate justification is provided
66.4.2 Adequate impact assessment is made (such that the
‘extension of target dates does not have an impact on
other systems).
66.4.3 _ Interim status report is attached with the justification
Critical element for determining the effectiveness of Corrective and
Preventive actions in the data or information is the confirmation that the
actions proposed were performed according to the expectations,
Not all corrective and preventive actions require assessment of
effectiveness.
The timeline and methodology to determine the effectiveness of CAPA
must be identified in an approved document where CAPA has been
identified and approved. (For e.g. 3 months after completion of CAPA),
Tools or approaches that may be used to assess the effectiveness of
CAPA include but are not limited to the following:
‘Approved By (Signature): ZS Qyyr—AR
Pharmalabs Ltd., India
STANDARD OPERATING PROCEDURE
TITLE: CORRECTIVE AND PREVENTIVE ACTIONS
(Current version)
SOP NO. CQA/005-00 | DEPARTMENT: Corporate Quality
Assurance
SUPERSEDES SOP RRAiniRS
EFFECTIVE iO PAGE NO.: fs
BATE: : 40 of 11 Copy
DATED: NA
6744 tograms &
[Link] Charts (for productivity improvement assessment)
[Link] Review of records (for documentation errors)
[Link] Visual Inspections (for reported on the job errors)
[Link] Interview with employees (training issues)
67.46 Mock drills
67.4.7 Unit Operations
7.0 REFERENCE(s)
Reference SOP No. Title
CQA/002 ‘Change Control System:
CQA003 Handling of Deviations
‘CQA/007. Handling of Incidents
‘CQA/008 Investigation of OOS Result
COA0I4 ‘Annual Product Review
‘CQAIOI7. Handling of Product Complaints
‘COA0IS Product Recall & Market Withdrawal
8.0 ABBREVIATION(s)
‘Abbreviation i
‘SOP ‘Standard Operating Procedure
No. ‘Number
CAPA Corrective action and preventive action
IN Incident
DV Deviation
cc ‘Change Control
MC Market Complaint
C@A001/F01-00
Approved By (Signature) BY. —AR
Pharmalabs Ltd., h
STANDARD OPERATING PROCEDURE
TITLE: CORRECTIVE AND PREVENTIVE ACTIONS
‘SOP NO.: CQa/00s-00 | DEPARTMENT: Corporate Quality
Assurance
SUPERSEDES SOP PS
EFFECTIVE PAGE NO.: (PRATER
ea ttoftt
9.0 FLOWCHART(s)
Attachment #1 (Flow chart for Management of CAPA).
10.0 ATTACHMENT(s)
Format No.
‘Attachment No.| Details/Title of Attachment (cameesicny
‘Attachment # 1 | Flow chart for Management of CAPA | CQA0O8/F01-00
‘Altncheient #2 | Comectiveiand Fraventive Action CQA005/F02-00
eport
44.0 CHANGE HISTORY
Change control No. Supersedes Effective Date
= None
Summary of Changes
ls New SOP
— Approved By (Signature): _